Uwe Trefzer
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
- Oncology 41
- Cutaneous Melanoma Detection and Management 16
- CAR-T cell therapy research 15
- Cancer Immunotherapy and Biomarkers 7
- Polyomavirus and related diseases 6
- Immunology 26
- Immunotherapy and Immune Responses 19
- Co-authors
- Dirk Schadendorf (11 shared papers)Peter Hersey (4 shared papers)Wolfram Sterry (25 shared papers)Claus Garbe (9 shared papers)Caroline Robert (3 shared papers)Jürgen Christian Becker (9 shared papers)Reinhard Dummer (6 shared papers)Peter Mohr (8 shared papers)
- Journals
- Annals of Oncology (7 papers)Journal of Clinical Oncology (7 papers)Melanoma Research (6 papers)Journal of Investigative Dermatology (5 papers)International Journal of Cancer (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Uwe Trefzer
87 papers receiving 8.7k citations
Uwe Trefzer's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 4.8k
- Immunology 1.7k
- Molecular Biology 4.5k
- Dermatology 479
- Cancer Research 555
Countries citing papers authored by Uwe Trefzer
This map shows the geographic impact of Uwe Trefzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Trefzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Trefzer more than expected).
Fields of papers citing papers by Uwe Trefzer
This network shows the impact of papers produced by Uwe Trefzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Trefzer. The network helps show where Uwe Trefzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Uwe Trefzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group Hit paper breakdown → | 2012 | 1225 |
| 2 | Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial Hit paper breakdown → | 2012 | 768 |
| 3 | The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma Hit paper breakdown → | 2013 | 755 |
| 4 | Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma Hit paper breakdown → | 2013 | 672 |
| 5 | Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group Hit paper breakdown → | 2006 | 505 |
| 6 | Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma Hit paper breakdown → | 2009 | 465 |
| 7 | 2013 | 416 | |
| 8 | 2013 | 372 | |
| 9 | 2015 | 355 | |
| 10 | 2008 | 288 | |
| 11 | 2013 | 201 | |
| 12 | 2011 | 165 | |
| 13 | 2017 | 158 | |
| 14 | 2016 | 138 | |
| 15 | 2011 | 134 | |
| 16 | 2008 | 127 | |
| 17 | 2010 | 121 | |
| 18 | 2011 | 105 | |
| 19 | 2007 | 94 | |
| 20 | 2003 | 94 |
About Uwe Trefzer
Uwe Trefzer is a scholar working on Oncology, Immunology, Dermatology, Molecular Biology and Immunology and Allergy, having authored 88 papers that have together received 9.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (19 papers), Melanoma and MAPK Pathways (17 papers), Cutaneous Melanoma Detection and Management (16 papers), CAR-T cell therapy research (15 papers), Cancer Immunotherapy and Biomarkers (7 papers), vaccines and immunoinformatics approaches (7 papers), Polyomavirus and related diseases (6 papers) and Hedgehog Signaling Pathway Studies (6 papers). The work is most often cited by research in Oncology (4.8k citations), Immunology (1.7k citations), Molecular Biology (4.5k citations), Dermatology (479 citations) and Cancer Research (555 citations). Uwe Trefzer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Dirk Schadendorf, Peter Hersey, Wolfram Sterry, Claus Garbe, Caroline Robert, Jürgen Christian Becker, Reinhard Dummer, Peter Mohr, Selma Ugurel and Peter Walden. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Melanoma Research, Journal of Investigative Dermatology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.